Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Timothy J. Kendall, Maria Jiménez Ramos, Frances Turner, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2939-2953
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Thyroid hormone receptor-beta agonists: new MASLD therapies on the horizon
Christopher D. Byrne, Giovanni Targher, Herbert Tilg
Gut (2024), pp. gutjnl-330596
Open Access | Times Cited: 14
Thyroid hormone receptor-β analogs for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Vlad Ratziu, Thomas S. Scanlan, Eveline Bruinstroop
Journal of Hepatology (2024)
Open Access | Times Cited: 9
Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress
Yongjie Zhang, Yangli Wang, Xin Liao, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Precision Oncology through Next Generation Sequencing in Hepatocellular Carcinoma
Sayali Shinde, Carola Maria Bigogno, A. S. Simmons, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42054-e42054
Open Access
Summary of the Year in Review Lectures at the 2024 Annual Meeting of the American Thyroid Association
Douglas Forrest, Jennifer A. Sipos, Elizabeth G. Grubbs
Thyroid (2025)
Closed Access
Usefulness of hepatic CT attenuation values in assessment of Fontan-associated liver disease progression: a comparative study with Model of End-stage Liver Disease Excluding International Normalized Ratio scores
Yosuke Kugo, Takashi Kido, Takuji Watanabe, et al.
Cardiology in the Young (2025), pp. 1-5
Open Access
Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease
Robert Chen, Ben Omega Petrazzini, Áine Duffy, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access
Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue
Alvile Kasarinaite, Maria Jiménez Ramos, Mariana Beltran-Sierra, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3
Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Nature (2025)
Open Access
Advancing the Metabolic Disfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook
Kushan Chowdhury, Debajyoti Das, Menghao Huang
Genes (2025) Vol. 16, Iss. 3, pp. 334-334
Open Access
Therapeutic Potential of Raspberry Extract in High-Fat Diet-Induced Liver Injury via Apoptosis and AMPK/PPARα Pathways
Fangying Xu, Jiannan Qiu, Nian Liu, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Association of niacin intake and metabolic dysfunction-associated steatotic liver disease: findings from National Health and Nutrition Examination Survey
Jing Zhou, Jun Hyun Han
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment
Richell Booijink, Prakash Ramachandran, Ruchi Bansal
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 614-627
Closed Access | Times Cited: 2
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19
Angus Jacobs, Steven D. Morley, Kay Samuel, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 31, pp. 3705-3716
Open Access | Times Cited: 2
Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease
Yifu Lyu, Xiuyi Yang, Lei Yang, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 385-398
Closed Access | Times Cited: 1
DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
Amal Magdy, Hee‐Jin Kim, Hanyong Go, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 824-844
Open Access | Times Cited: 1
Outcome prediction in metabolic dysfunction‐associated steatotic liver disease using stain‐free digital pathological assessment
Timothy J. Kendall, Elaine Chng, Yayun Ren, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2511-2516
Open Access | Times Cited: 1
Epidemiological Study on the Interaction between the PNPLA3 (rs738409) and Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease
Satoshi Sato, Chikara Iino, Takafumi Sasada, et al.
Genes (2024) Vol. 15, Iss. 9, pp. 1172-1172
Open Access | Times Cited: 1
Diabetes risk reduction diet and risk of liver cancer and chronic liver disease mortality: A prospective cohort study
Yun Chen, Longgang Zhao, Su Yon Jung, et al.
Journal of Internal Medicine (2024) Vol. 296, Iss. 5, pp. 410-421
Closed Access | Times Cited: 1
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver
Andrew Perry, Niran Hadad, Emeli Chatterjee, et al.
Cell Reports Medicine (2024), pp. 101871-101871
Open Access | Times Cited: 1
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver
Andrew Perry, Niran Hadad, Emeli Chatterjee, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update
Jonathan A. Fallowfield, Maria Jiménez Ramos
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 187-192
Open Access | Times Cited: 1
Epigenetic regulation of thyroid hormone action in human metabolic dysfunction associated steatohepatitis
Alison-Michelle Naujack, Christin Krause, Jan H. Britsemmer, et al.
European Thyroid Journal (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 1
A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease
Maria Jiménez Ramos, Timothy J. Kendall, Ignat Drozdov, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101278-101278
Open Access | Times Cited: 3
The Aqueous Extract of Rubus Corchorifolius L. Fruit Supplementation Ameliorates Hepatic Steatosis and Apoptosis in Mafld Through Ampk/Pparα Signaling Pathway
Fangying Xu, Jiannan Qiu, Nian Liu, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top